Oxford Finance Closes $4 Million Debt Facility with IntelliCyt Corporation - WICU12 HD WSEE Erie, PA News, Sports, Weather and Events

Oxford Finance Closes $4 Million Debt Facility with IntelliCyt Corporation

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Oxford Finance LLC

ALEXANDRIA, Va., June 10, 2014 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $2.5 million senior secured term loan agreement and a $1.5 million revolving line of credit with IntelliCyt Corporation ("IntelliCyt"). Proceeds of the loan will be used for working capital and to support the company's product development and marketing initiatives.

"Oxford is pleased to provide financing to accelerate IntelliCyt's growth," said Christopher A. Herr, managing director for Oxford Finance. "IntelliCyt's experienced management team has created a capital-efficient business that offers an innovative suite of cell and bead-based screening solutions for its clients."

"Oxford has provided a flexible financing package that will support our working capital needs and commercial expansion as we continue our rapid revenue growth," commented Dennis Hynson, chief financial officer for IntelliCyt.

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $2 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Massachusetts, Illinois and North Carolina. For more information visit www.oxfordfinance.com.

About IntelliCyt Corporation

IntelliCyt Corporation develops innovative, high-throughput, high-content cell- and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery and in vitro toxicity testing. IntelliCyt's proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology, and life science research. For more information, please visit www.intellicyt.com.

  

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
3514 State St. Erie, PA 16508
Newsroom: (814)454-8812
Toll Free: 1(800)454-8812
Business offices: (814)454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
Mobile:
Mobile Site
Be sure to stay constantly updated with the power of WICU12 and WSEE at your fingertips
Free Android App
Free iPhone App
Free iPad App
Storm Tracker App
Droid
iPhone
iPad
All content © Copyright 2000 - 2014 WorldNow and WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com